JagsonpalPharmaceuticals JAGSNPHARM full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

• Tips
• NEWS
• Tomorrow
• Forecast
• Targets
• ExpertsView
• Analysis
• Munafa AI prediction

• IntraDay predictions, targets, What to do JAGSNPHARM
• Forcast & Targets JAGSNPHARM
• JAGSNPHARM Experts view
• Tomorrow's Movement JAGSNPHARM
• Technical Analysis Reports
• All in One Charts
• All indicators in One Charts
• JAGSNPHARM History
• Money flow charts
• Weekly charts
• Monthly charts
• Moving averages charts
• MACD charts
• Force Index charts
• Stochastics charts
• PVM charts
• RSI and MRSI charts
• Renko charts
• Point and Figure charts

Daily Price and Volume

Weekly Price and Volume

Monthly Price and Volume

Yearly Price and Volume

Indicator Analysis of JagsonpalPharmaceuticals

Tomorrow's movement Prediction of Jagsonpal Pharmaceuticals JAGSNPHARM appears to be in downtrend.

And this trend seems to be continuing further.

Price is above an important level of 201.82 on charts, and as long as price remains above this level, the uptrend of stock might continue.

Tomorrow's movement Prediction of Jagsonpal Pharmaceuticals JAGSNPHARM appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.

Munafa value: 40 as on Tue 23 December 2025

This Munafa value indicates that the stock is moving downwards and might continue to move down.

SMA20 is at 206 and price is deviating by 8 points

Upper Bollinger band is at 220 and lower is at 191, while middle bands are at 199 and 213

Price is rising

Price is below 20day SMA

Price is in upper range of bands

Price action analysis of JagsonpalPharmaceuticals (JAGSNPHARM) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

ADX buy sell signal for JagsonpalPharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for JagsonpalPharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

JagsonpalPharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for JagsonpalPharmaceuticals in short term and BUY signal is strong.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of JagsonpalPharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 200.22 and JagsonpalPharmaceuticals JAGSNPHARM stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the JagsonpalPharmaceuticals JAGSNPHARM stock. Volume based technical analysis of JagsonpalPharmaceuticals JAGSNPHARM stock is negative.

JagsonpalPharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Jagsonpal Pharmaceuticals JAGSNPHARM

DMA (daily moving average) of Jagsonpal Pharmaceuticals JAGSNPHARM

DMA period	DMA value
5 day DMA	200.18
12 day DMA	200.42
20 day DMA	205.27
35 day DMA	207.06
50 day DMA	210.82
100 day DMA	226.61
150 day DMA	229.45
200 day DMA	226.94

EMA (exponential moving average) of Jagsonpal Pharmaceuticals JAGSNPHARM

EMA period	EMA current	EMA prev	EMA prev2
5 day EMA	200.48	199.72	200.23
12 day EMA	201.81	201.78	202.34
20 day EMA	203.7	203.88	204.43
35 day EMA	207.32	207.63	208.16
50 day EMA	210.29	210.63	211.12

SMA (simple moving average) of Jagsonpal Pharmaceuticals JAGSNPHARM

SMA period	SMA current	SMA prev	SMA prev2
5 day SMA	200.18	199.38	199.61
12 day SMA	200.42	200.96	202.57
20 day SMA	205.27	205	205.03
35 day SMA	207.06	207.75	208.44
50 day SMA	210.82	211.2	211.5
100 day SMA	226.61	227.48	228.42
150 day SMA	229.45	229.51	229.6
200 day SMA	226.94	226.95	226.99

Fundamentals, profit and EPS of Jagsonpal Pharmaceuticals JAGSNPHARM

EPS is 9.32 and PE is: 21.67

Last quarter profit: (September 2025 quarter) 12.57 crores (9.69%)

Debt: 8.84 in crores

Market capitalization: 1337.35

EPS is 9.16 and PE is: 22.05

Last quarter profit: (June 2025 quarter) 10.80 crores (38.64%)

Debt: 9.24 in crores

Market capitalization: 1556.97

Videos related to: JagsonpalPharmaceuticals JAGSNPHARM full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI